Added to YB: 2023-10-13
Pitch date: 2023-10-13
ALNY [bullish]
Alnylam Pharmaceuticals, Inc.
+102.08%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
Market Cap
$41.7B
Pitch Price
$167.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
66.11
P/E
134.94
EV/Sales
11.24
Sector
Biotechnology
Category
N/A
Show full summary:
Alnylam Pharmaceuticals, Inc ALNY
A summary for this pitch has not been created yet.
Read full article (0 min)